Products

Products

Home page

Drug Products

News Center

Viwit Pharmaceuticals' Sterile Production Facility Successfully Passes U.S. FDA Inspection

Viwit Pharmaceutical's Phenylephrine Hydrochloride Injection Officially Receives Official Approval by China NMPA

Viwit Pharmaceuticals’ Brimonidine tartrate and Timolol maleate eye drops receive Official Approval by China NMPA

Viwit's Nitroglycerin Sublingual Tablets Approved by FDA

Viwit Pharmaceuticals API Site Successfully Passed FDA cGMP On-site Audit with "No Action Indicated"

Viwit Pharmaceutical Co. Ltd. announces exclusive licensing and supply agreement for two Gadolinium based Magnetic Resonance Imaging (MRI) injectable contrast agents in the US.

← BACK Return

Puerarin Injection 5ml: 0.25g

【Drug Name】

Generic Name：Puerarin Injection

【Strength】

5ml: 0.25g

【Approval Status】

NMPA approval No.: H20057873

【Indication】

For adjuvant treatment of coronary heart disease, angina pectoris, myocardial infarction, retinal artery, vein occlusion, and sudden deafness.

Refers to drug instructions for details.

VIWIT

Technical Support:China Enterprise Cross-border | SEO Tags

【Business License】

Search